Recent Insider Transactions - Monopar Therapeutics (NASDAQ: MNPR)

Company

Name / Role

Date

Type

Price

# Shares

Value

Balance

NASDAQ MNPR Monopar Therapeutics

Cittadine Andrew / officer: Chief Operating Officer

09/30/2025

Sell

$81.67

1,896

$155K

48,289

NASDAQ MNPR Monopar Therapeutics

Robinson Chandler / director, officer: Chief Executive Officer

09/30/2025

Sell

$81.67

2,646

$216K

79,552

NASDAQ MNPR Monopar Therapeutics

Tactic Pharma LLC / 10 percent owner

09/24/2025

Sell

$63.61

550,229

$35.000M

272,026